MD3244889T2 - Compoziţie farmaceutică pentru tratamentul micozei - Google Patents

Compoziţie farmaceutică pentru tratamentul micozei

Info

Publication number
MD3244889T2
MD3244889T2 MDE20170279T MDE20170279T MD3244889T2 MD 3244889 T2 MD3244889 T2 MD 3244889T2 MD E20170279 T MDE20170279 T MD E20170279T MD E20170279 T MDE20170279 T MD E20170279T MD 3244889 T2 MD3244889 T2 MD 3244889T2
Authority
MD
Moldova
Prior art keywords
mycosis
treatment
pharmaceutical composition
combination
benzidamine
Prior art date
Application number
MDE20170279T
Other languages
English (en)
Inventor
Claudio Milanese
De Joannon Alessandra Capezzone
Serena Tongiani
Luca Donati
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of MD3244889T2 publication Critical patent/MD3244889T2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)

Abstract

Prezenta invenţie se referă la o compoziţie farmaceutică care conţine o combinaţie de benzidamină şi un ingredient activ antimicotic, combinaţia menţionată având un efect sinergic în tratamentul micozei.
MDE20170279T 2015-01-13 2016-01-08 Compoziţie farmaceutică pentru tratamentul micozei MD3244889T2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15150904 2015-01-13
PCT/EP2016/050272 WO2016113194A1 (en) 2015-01-13 2016-01-08 Pharmaceutical composition for the treatment of mycosis

Publications (1)

Publication Number Publication Date
MD3244889T2 true MD3244889T2 (ro) 2020-06-30

Family

ID=52396443

Family Applications (1)

Application Number Title Priority Date Filing Date
MDE20170279T MD3244889T2 (ro) 2015-01-13 2016-01-08 Compoziţie farmaceutică pentru tratamentul micozei

Country Status (29)

Country Link
US (1) US9962372B2 (ro)
EP (1) EP3244889B1 (ro)
JP (1) JP6714597B2 (ro)
KR (1) KR102606081B1 (ro)
CN (1) CN107106690B (ro)
AR (1) AR103381A1 (ro)
AU (1) AU2016208200B2 (ro)
BR (1) BR112017014295B1 (ro)
CA (1) CA2970060C (ro)
CY (1) CY1122979T1 (ro)
DK (1) DK3244889T3 (ro)
EA (1) EA035748B1 (ro)
ES (1) ES2794824T3 (ro)
GE (1) GEP20196962B (ro)
HK (1) HK1246146A1 (ro)
HR (1) HRP20200815T1 (ro)
HU (1) HUE049877T2 (ro)
IL (1) IL252774A0 (ro)
LT (1) LT3244889T (ro)
MD (1) MD3244889T2 (ro)
ME (1) ME03736B (ro)
MX (1) MX2017008879A (ro)
PL (1) PL3244889T3 (ro)
PT (1) PT3244889T (ro)
RS (1) RS60508B1 (ro)
SG (1) SG11201704964RA (ro)
SI (1) SI3244889T1 (ro)
UA (1) UA120864C2 (ro)
WO (1) WO2016113194A1 (ro)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109562058A (zh) 2016-07-08 2019-04-02 方济各安吉利克化学联合股份有限公司 包含苄达明的药物组合物
CN112514904B (zh) * 2021-01-26 2021-10-26 青岛农业大学 盐酸苄达明在制备用于防治由植物病原菌引起的植物病害的杀菌剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224598D0 (en) 1992-11-24 1993-01-13 Smithkline Beecham Plc Novel compositions
IT1274655B (it) * 1995-02-28 1997-07-18 Smithkline Beecham Farma Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico
US6913759B2 (en) * 2003-03-11 2005-07-05 Curatek Pharmaceuticals Holding, Inc. Gel composition and method for treatment of vaginal infections
CA2651726C (en) 2006-05-12 2015-12-15 Pharmacon - Forschung Und Beratung Gmbh Use of combination preparations, comprising antimycotics
CN1887352A (zh) * 2006-07-13 2007-01-03 徐艳 治疗眼部真菌和细菌感染的组合物
GB201000196D0 (en) * 2010-01-07 2010-02-24 Galvez Julian M Novel combination

Also Published As

Publication number Publication date
CN107106690B (zh) 2020-11-10
BR112017014295B1 (pt) 2023-04-25
WO2016113194A1 (en) 2016-07-21
CA2970060C (en) 2023-10-03
HK1246146A1 (zh) 2018-09-07
CA2970060A1 (en) 2016-07-21
US20180000783A1 (en) 2018-01-04
GEP20196962B (en) 2019-04-10
MX2017008879A (es) 2018-03-28
DK3244889T3 (da) 2020-06-02
KR20170101941A (ko) 2017-09-06
BR112017014295A2 (pt) 2018-03-06
ES2794824T3 (es) 2020-11-19
SI3244889T1 (sl) 2020-08-31
JP2018501277A (ja) 2018-01-18
IL252774A0 (en) 2017-08-31
HUE049877T2 (hu) 2020-10-28
JP6714597B2 (ja) 2020-06-24
HRP20200815T1 (hr) 2020-08-07
ME03736B (me) 2021-01-20
EA035748B1 (ru) 2020-08-05
EP3244889A1 (en) 2017-11-22
CN107106690A (zh) 2017-08-29
UA120864C2 (uk) 2020-02-25
RS60508B1 (sr) 2020-08-31
KR102606081B1 (ko) 2023-11-24
CY1122979T1 (el) 2021-10-29
AU2016208200B2 (en) 2020-09-03
LT3244889T (lt) 2020-08-10
AR103381A1 (es) 2017-05-03
SG11201704964RA (en) 2017-07-28
US9962372B2 (en) 2018-05-08
EA201791483A1 (ru) 2017-11-30
AU2016208200A1 (en) 2017-06-29
PT3244889T (pt) 2020-06-04
EP3244889B1 (en) 2020-03-04
PL3244889T3 (pl) 2020-11-02

Similar Documents

Publication Publication Date Title
MX2018013983A (es) Inhibidores g12c de kras.
BR112016026291A2 (pt) Derivados do ácido borônico e usos terapêuticos dos mesmos
EA201791454A1 (ru) Лекарственные формы для трансдермального введения
EA201690039A1 (ru) Ингибиторы rorc2 и способы их применения
MA49837A (fr) Compositions pharmaceutiques
TR201901228T4 (tr) Vortioksetin piroglutamat.
CO2017007316A2 (es) Formulación farmacéutica
DK3445331T3 (da) Farmaceutiske oftalmiske sammensætninger uden konserveringsmidler
CY1122979T1 (el) Φαρμακευτικη συνθεση για τη θεραπεια της μυκητιασης
DK4058148T3 (da) Doseringsregime for anti-bcma-midler
CL2018003338A1 (es) Formulaciones inyectables fisiológicamente balanceadas de fosnetupitant.
EA201692493A1 (ru) Противомикробные фармацевтические композиции со способностями ингибирования множественной лекарственной устойчивости
FR3025096B1 (fr) Composition gel/gel contenant un actif anti-transpirant
CY1124229T1 (el) Συνδυασμος τραζοδονης και γκαμπαπεντινης για την αντιμετωπιση του πονου
HUE051163T2 (hu) Szabad gyökökkel szemben antioxidáns aktivitással és gyulladásgátló aktivitással rendelkezõ vegyületek és megfelelõ gyógyszerkészítmények bõrápoláshoz
CL2015002642A1 (es) Anticuerpo monoclonal, inhibiendo la actividad enzimática de la lipasa endotelial vascular.
EA201501130A1 (ru) Офтальмологическая фармацевтическая композиция
EA201891848A1 (ru) Фармацевтическая композиция для применения в лечении фиброза
MA49625A (fr) Compositions pharmaceutiques
EA201990041A1 (ru) Композиции, содержащие тимолол, и их применение при лечении розацеа при местном применении
EA201890477A1 (ru) Инкапсулированная композиция финголимода
EA201991733A1 (ru) Фармацевтические композиции для комбинированной терапии
UA120448U (uk) Фунгіцидна композиція
DK3558261T3 (da) Farmaceutiske sammensætninger omfattende safinamid
EA201992151A1 (ru) Фармацевтические композиции для комбинированной терапии